Underrepresentation of female subjects in BE study to register Generic [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-15 10:43 (1500 d 06:11 ago) – Posting: # 21275
Views: 4,258

❝ You are trying not to use female subjects because they caused your study to fail. That alone is not a good justification.


Hi Jag,

Thanks for your suggestion. What do you think should be the ratio of M:Fe, wherein you know that more female you take, the more closer you get to bioinequivalency. Whats your take?

Cheers,
SKM


Edit: Standard quotes restored; see also this post #8[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,991 posts in 4,827 threads, 1,648 registered users;
55 visitors (1 registered, 54 guests [including 5 identified bots]).
Forum time: 17:55 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5